SHANNON VICKERS: Open Payments
NPI 1528494150 · EVANSVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,299 in 49 payments from 17 companies in 2025. Trend: 2023 $500 · 2024 $780 · 2025 $1,299
Food & beverage: $1,199Education: $99
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 6 | $246 |
| Galderma Laboratories, L.P. | 4 | $223 |
| Novartis Pharmaceuticals Corporation | 7 | $127 |
| GENZYME CORPORATION | 4 | $108 |
| CSL Behring | 5 | $104 |
| Amgen Inc. | 4 | $83 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $79 |
| GlaxoSmithKline, LLC. | 4 | $69 |
| Genentech USA, Inc. | 2 | $53 |
| Optinose US, Inc. | 2 | $42 |
Products named: DUPIXENT, NEMLUVIO, XOLAIR, TEZSPIRE, NEFFY, Xhance, Andembry, Rhapsido.
Industry payments across IN — which companies pay providers there.
